Press Release

March 30, 2006: CFD Therapeutics Formed To Advance Novel Monoclonal Antibodies For Cancer - More Information

Below:

Immunohistochemical staining of a CFD therapeutic target in human ovarian cancer.

Welcome to CFD Therapeutics

Overview

CFD Therapeutics, Inc. (CFD) is a privately held biotechnology company based in South San Francisco, California, formed through a spin-out from diaDexus, Inc. CFD is focused on development of novel therapeutic monoclonal antibodies directed against rigorously validated, proprietary solid tumor targets.